Severe complications of tramadol overdose in Iran.

Paria Habibollahi,Alireza Garjani,Samad Shams Vahdati,Seyyed-Reza Sadat-Ebrahimi,Neda Parnianfard

doi:10.4178/epih.e2019026

Paria Habibollahi, Alireza Garjani + Show 3 more

Open Access

https://doi.org/10.4178/epih.e2019026

Copy DOI

Abstract

OBJECTIVESSevere complications of tramadol overdose have been reported; however, few large-scale studies have investigated this issue. Therefore, this study aimed to explore the presentation and complications of tramadol overdose in patients admitted to an intoxication referral center in northwestern Iran.METHODSPatients with tramadol overdose admitted to Sina Teaching Hospital in Tabriz, Iran during 2013-2017 were included. For each patient, the following data were collected: demographics, previous drug or medication overdose, whether the patient was in the process of quitting drug use, ingested dose of tramadol and co-ingestants, Glasgow Coma Scale (GCS) score, clinical symptoms at the time of admission, and admission characteristics. Serotonin toxicity was diagnosed in patients who fit the Hunter criteria. Multiple logistic regression was performed to identify variables associated with the incidence of severe complications of tramadol overdose.RESULTSIn total, 512 cases of tramadol overdose were evaluated, of which 359 patients were included, with a median age of 41 years (range, 16-69) and a median tramadol dose of 1,500 mg (range, 500-4,000). The most frequent complications associated with tramadol overdose were hypertension (38.4%), tachycardia (24.8%), and seizure (14.5%). No serotonin toxicity was detected in patients. Having a GCS score <15, having taken a tramadol dose of >1,000 mg, being in the process of quitting drug use, being 30-49 years old, and male sex were significantly related to the incidence of severe complications of tramadol overdose.CONCLUSIONSAlthough seizure was prevalent among Iranian patients with tramadol poisoning, serotonin toxicity and cardiogenic shock were rare findings.

Highlights

Using a pre-prepared checklist, data were gathered on patients’ demographics, previous history of overdose of any drugs or medications, whether they were in the process of quitting drug use, the Glasgow Coma Scale (GCS) score, ingested dose of tramadol and co-ingestants, clinical symptoms and noteworthy complications during the time of admission, length of stay (LOS), the ward or unit of admission, and administration of mechanical ventilation
Based on the results of the backward logistic regression model for variables associated with the incidence of severe complications of tramadol overdose, having a GCS score of 15 or lower, an ingested tramadol dose higher than 1,000 mg, being in the process of quitting drug use, being 30-49 years old, and male sex were significantly related to the incidence of severe complications of tramadol overdose (Table 3)
This may have occurred because serotonin toxicity as a consequence of tramadol overdose is more likely to occur when tramadol is concomitantly ingested with other drugs, especially tricyclic antidepressants (TCAs) [14,15]; we excluded such patients from our study to analyze the effects of unadulterated tramadol

Summary

Introduction

Tramadol is one of the most widely used opioid drugs in medicine, and is mainly prescribed as a centrally-acting analgesic for. Tramadol is a synthetic 4-phenyl-piperidine analog of codeine, and its opioid effects are due to interactions with μ receptors, leading to effects on the noradrenergic and serotonergic systems through norepinephrine and serotonin reuptake inhibition, respectively, in the central nervous system (CNS) [2]. It results in affecting the neurotransmitter gamma-aminobutyric acid (GABA) manifestations through increasing the levels of GABA mediators in the CNS [3].

Objectives

Methods

Results

Conclusion